For the longest time, clinicians have treated cardiovascular disease by focusing on diabetes and blood pressure control, reducing cholesterol using medications like aspirin and statins.
A study led by Michigan Medicine has uncovered that suPAR, a protein, causes atherosclerosis, linking cardiovascular disease and kidney disease. The research shows potential for suPAR to be a treatment target for both conditions.
Clinicians have traditionally treated cardiovascular disease by focusing on diabetes and blood pressure control, as well as lowering cholesterol with drugs such as aspirin and statins.
Get latest articles and stories on Health at LatestLY. Clinicians have traditionally treated cardiovascular disease by focusing on diabetes and blood pressure control, as well as lowering cholesterol with drugs such as aspirin and statins. Health News | Scientists Discover New Immune Target to Treat Cardiovascular Disease.